Sagimet Biosciences Inc. Ratios

Ratios Dec2023
Profitability
EBT Margin -1,394.00%
EBIT Margin -1,537.00%
EBITDA Margin -1,388.10%
Operating Margin -1,537.00%
Net Margin -1,394.00%
FCF Margin -1,188.30%
Efficiency
Invested Capital 91.06M
Leverage & Solvency
Equity Ratio 0.94
Valuation
Enterprise Value 29.20M
Market Capitalization 124.10M
Return Ratios
Return on Sales -13.94%